✦ LIBER ✦

Study of the safety and tolerability of Simulect® (basiliximab) versus OKT3 in heart transplantation

✍ Scribed by M.G. Crespo-Leiro; J.L. Rodriguez-Lambert; J.L. Segovia; L. Almenar; E. Roig; M.A. Gómez-Sánchez; E. Lage; N. Manito; L.A. Pulpon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final results of the study of safety and

✍ J.L Rodríguez Lambert; M.G Crespo Leiro; J Segovia; L Almenar; E Roig; M.A Gómez 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Improved safety of basiliximab (Simulect

✍ M.F. Mattei; P. Boissonnat; M. Redonnet; I. Gandjbakhch; A. Mouly Bandini; R. Do 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 66 KB

The promise of C2, simulect, and certica

✍ D.H Delgado; H.J Ross 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Open-Label, Multicenter Study on the Saf

✍ A. Turconi; L. Rodriguez Rilo; J. Goldberg; G. de Boccardo; A. Garsd; A. Otero 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Safety and efficacy of an alternative ba

✍ Ivo Matl,Petr Bachleda,Mieczyslaw Lao,Rudolf Michalský… 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 236 KB

Safety and efficacy of an alternative ba

✍ Ivo Matl; Petr Bachleda; Mieczyslaw Lao; Rudolf Michalský; Pavel Navrátil; Vladi 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 768 KB